FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
DIMENSION VISTA FREE THYROXINE FLEX REAGENT CARTRIDGE, FT4, DIMENSION VISTA THYROID STIMULATING HORMONE FLEX REAGENT
K Number: K140859
·
Decision Nov 26, 2014
Classifications
1
FEI Numbers
43
Registration Numbers
43
Same Product Code
91
Applicant Total
152
Review Days
237
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- DIMENSION VISTA FREE THYROXINE FLEX REAGENT CARTRIDGE, FT4, DIMENSION VISTA THYROID STIMULATING HORMONE FLEX REAGENT
- K Number
- K140859
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 862.1695
- Medical Specialty
- Clinical Chemistry
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Siemens Healthcare Diagnostics, Inc.
- Date Received
- April 3, 2014
- Decision Date
- November 26, 2014
- Product Code
- CEC
- Advisory Committee
- Clinical Chemistry
- Review Advisory Committee
- CH
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| CEC | Radioimmunoassay, Free Thyroxine | FDA class 2 | Clinical Chemistry |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (CEC), ordered by most recent decision date.
Access Free T4
FDA 510(k)
FDA Class 2
·Clinical Chemistry
Elecsys FT4 IV
FDA 510(k)
FDA Class 2
·Clinical Chemistry
MAGLUMI 2000 FT4
FDA 510(k)
FDA Class 2
·Clinical Chemistry
Elecsys FT4 III
FDA 510(k)
FDA Class 2
·Clinical Chemistry
Abbott Architect Free T4
FDA 510(k)
FDA Class 2
·Clinical Chemistry
FREND Free T4 Test System
FDA 510(k)
FDA Class 2
·Clinical Chemistry
Other Clearances by Siemens Healthcare Diagnostics, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K251998 | Atellica CH Diazo Total Bilirubin (D_TBil) | Feb 27, 2026 | Substantially Equivalent |
| K251543 | Atellica® IM TSH3-Ultra II (TSH3ULII) | Feb 6, 2026 | Substantially Equivalent |
| K251630 | Atellica IM Total PSA II (tPSAII) | Jan 5, 2026 | Substantially Equivalent |
| K250816 | ADVIA Centaur Anti-Thyroglobulin II (aTgII) | Dec 4, 2025 | Substantially Equivalent |
| K250250 | ADVIA Centaur Anti-Thyroid Peroxidase II | Oct 17, 2025 | Substantially Equivalent |
| K242981 | Atellica IM Thyroglobulin (Tg) | Jun 20, 2025 | Substantially Equivalent |
| K242685 | Atellica® CH Creatinine_3 (Crea3) | Dec 4, 2024 | Substantially Equivalent |
| K241800 | Atellica® CH HDL Cholesterol (HDLC)& Atellica® CH LDL Cholesterol (LDLC) | Jul 26, 2024 | Substantially Equivalent |
| K241165 | Atellica® IM High-Sensitivity Troponin I (TnIH) | Jul 25, 2024 | Substantially Equivalent |
| K233050 | ADVIA Centaur® TSH3-Ultra II (TSH3ULII) | Apr 4, 2024 | Substantially Equivalent |